Ashley Hopkins, NP
Gerontology · Fort Worth, TXNPI 1669928891
Payments from drug & device makers
Across 39 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$185
- Alkermes, Inc.$118
- Indivior Inc.$114
- Otsuka America Pharmaceutical, Inc.$103
- Vanda Pharmaceuticals Inc.$81
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$59
- plus $75 from 4 others
What the payments were for
- Food & beverage$735100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 9 | $185 |
| Alkermes, Inc. | 6 | $118 |
| Indivior Inc. | 7 | $114 |
| Otsuka America Pharmaceutical, Inc. | 5 | $103 |
| Vanda Pharmaceuticals Inc. | 4 | $81 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $59 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| GSK | 1 | $19 |
| Lundbeck LLC | 1 | $13 |
How this compares
$735 in reported general payments places this provider in the 60th percentile of 653 gerontology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 66 | $103,091 |
| JanuviaSitagliptin Phosphate | 32 | $51,082 |
| TrulicityDulaglutide | 25 | $45,767 |
| EliquisApixaban | 23 | $32,589 |
| TradjentaLinagliptin | 13 | $15,246 |
| Spiriva HandihalerTiotropium Bromide | 13 | $7,075 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $4,394 |
| Gabapentin | 101 | $3,258 |
| LantusInsulin Glargine,hum.Rec.Anlog | 18 | $3,180 |
| Tolterodine Tartrate ErTolterodine Tartrate | 15 | $2,451 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 84 | $2,407 |
| Atorvastatin Calcium | 242 | $1,966 |
| Famotidine | 72 | $1,504 |
| Clobetasol Propionate | 33 | $1,325 |
| Pregabalin | 14 | $1,302 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Fort Worth
- Jennifer WestFort Worth$67K
- Patricia MagnessFort Worth$5K
- Kimberly PoseyFort Worth$4K
- Kimberly WelchCoppell$113K
- Tiffany KesslerDallas$84K
- Meagan ChavarriaHouston$40K
- Bailey EstesAbilene$34K
- Scott ZelaHouston$28K
- Marissa Marti-SmithDallas$27K
- Andrew BargerAustin$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.